News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EPO Rules BioPorto’s NGAL Cutoff-Patent Invalid


4/1/2014 9:44:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Today, the European Patent Office (EPO) has decided that BioPorto's NGAL cutoff patent no. EP1831699 does not meet the requirements for adequate description. The patent is thus ruled invalid.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES